Research in ovarian cancer is ongoing, with a focus on improving early detection, treatment options, and understanding the molecular basis of the disease. Clinical trials are exploring new drugs, combinations of existing treatments, and innovative approaches like personalized medicine. Advances in genomic profiling and biomarkers are promising for the future of ovarian cancer management.
